Saturday 17 October 2026
Export LGMK’s income statement to Excel — free account
LogicMark, Inc.
LGMK Healthcare Health Information Services
LogicMark, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS grew 35.4% and free cash flow grew 96.4%, each against the same quarter a year earlier.
1.30
0.10
+8.33%
Follow LGMK
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.16 | 0.04 | 0.04 | 0.04 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(2.28) | (0.25) | (0.30) | 6.16 | |
P/B ratio |
0.10 | 0.03 | 0.03 | 0.04 | |
Price to Tangible BV |
0.14 | 0.04 | 0.05 | 0.06 | |
EV/Sales |
(0.56) | (0.44) | (0.24) | (0.16) | |
EV/EBITDA |
0.91 | 0.87 | 0.61 | 0.49 | |
EV/Operating CF |
1.33 | 0.99 | 0.58 | 0.52 | |
EV/FCF |
0.30 | 0.25 | 0.14 | 0.11 | |
Quick Ratio |
4.86 | 4.93 | 4.71 | 3.73 | |
Current Ratio |
5.61 | 6.00 | 6.30 | 4.88 | |
Net Debt/EBITDA |
9.49 | 8.91 | 8.51 | 6.75 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.55 | 0.66 | 0.55 | 0.62 | |
Operating CF/Net income |
0.45 | 0.98 | 1.08 | (0.05) | |
Capex/Depreciation |
(0.85) | (0.55) | (0.48) | (0.69) | |
Research and Development Expense of Revenue |
5.54% | 5.29% | 3.84% | 2.73% | |
Selling, General and Administrative Expense of Revenue |
89.44% | 86.45% | 81.28% | 85.87% | |
Intangible Assets out of Total Assets |
0.21 | 0.22 | 0.24 | 0.25 | |
Share Based Compensation of Revenue |
4.76% | 8.85% | 2.48% | 12.89% | |
Graham Net Nets |
5.20 | 18.19 | 13.00 | 9.42 | |
Graham Number |
3,675.52 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
1,170,687.19% | (14,182.61%) | (1,601.91%) | (1,343.86%) | |
Free Cash Flow Yield |
(1,148.55%) | (4,904.67%) | (4,199.34%) | (3,778.81%) | |
Revenue per Share |
3.79 | 5.15 | 3.55 | 3.72 | |
Operating CF per Share |
(0.99) | (2.76) | (1.82) | 0.09 | |
Capex per Share |
(0.56) | (0.56) | (0.33) | (0.47) | |
Free Cash Flow per Share |
(1.55) | (3.31) | (2.15) | (0.38) | |
Cash per Share |
15.21 | 15.99 | 8.26 | 7.37 | |
Shareholders Equity per Share |
23.21 | 27.37 | 16.38 | 14.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
23.21 | 27.37 | 16.38 | 14.66 | |
Free Cash Flow |
(1.19) | (1.97) | (1.95) | (0.34) | |
Working Capital |
11.11 | 9.67 | 8.44 | 6.89 | |
Capital Expenditures |
(0.43) | (0.33) | (0.30) | (0.42) | |
Net Current Asset Value |
8.98 | 7.58 | 6.36 | 4.83 | |
EV/EBIT |
0.70 | 0.64 | 0.42 | 0.32 | |
Capex to Sales |
0.15 | 0.11 | 0.09 | 0.13 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.06 | 0.01 | 0.12 | 0.08 | |
Average Payables |
0.60 | 0.66 | 0.65 | 0.54 | |
Average Inventory |
0.93 | 1.22 | 1.27 | 0.99 | |
Average Assets |
19.21 | 17.26 | 21.86 | 20.24 | |
Average Common Equity |
14.78 | 12.78 | 17.70 | 16.14 |
Columns are period end dates